From the Department of Radiology, Kantonsspital Graubuenden, Loestrasse 170, 7000 Chur, Switzerland (N.K.); Collaborative Health Studies Coordinating Center, University of Washington, Seattle, Wash (R.K.); Department of Radiology and Radiological Science (J.E.) and Division of Cardiology (J.A.C.L.), Johns Hopkins University, Baltimore, Md; Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minn (A.F.); Department of Public Health Sciences, Wake Forest University, Winston-Salem, NC (G.B.); Department of Radiology, Vanderbilt University Medical Center, Nashville, Tenn (J.J.C.); Department of Medicine, Columbia University, New York, NY (S.S.); and Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wis (D.A.B.).
Radiology. 2019 Oct;293(1):107-114. doi: 10.1148/radiol.2019182871. Epub 2019 Aug 27.
Background Few data exist on the long-term risk prediction of elevated left ventricular (LV) mass quantified by MRI for cardiovascular (CV) events in a contemporary, ethnically diverse cohort. Purpose To assess the long-term impact of elevated LV mass on CV events in a prospective cohort study of a multiethnic population in relationship to risk factors and coronary artery calcium (CAC) score. Materials and Methods The Multi-Ethnic Study of Atherosclerosis, or MESA (: NCT00005487), is an ongoing prospective multicenter population-based study in the United States. A total of 6814 participants (age range, 45-84 years) free of clinical CV disease at baseline were enrolled between 2000 and 2002. In 4988 participants (2613 [52.4%] women; mean age, 62 years ± 10.1 [standard deviation]) followed over 15 years for CV events, LV mass was derived from cardiac MRI at baseline enrollment by using semiautomated software at a central core laboratory. Cox proportional hazard models, Kaplan-Meier curves, and scores were applied to assess the impact of LV hypertrophy. Results A total of 290 participants had hard coronary heart disease (CHD) events (207 myocardial infarctions [MIs], 95 CHD deaths), 57 had other CV disease-related deaths, and 215 had heart failure (HF). LV hypertrophy was an independent predictor of hard CHD events (hazard ratio [HR]: 2.7; 95% confidence interval [CI]: 1.9, 3.8), MI (HR: 2.8; 95% CI: 1.8, 4.0), CHD death (HR: 4.3; 95% CI: 2.5, 7.3), other CV death (HR: 7.5; 95% CI: 4.2, 13.5), and HF (HR: 5.4; 95% CI: 3.8, 7.5) ( < .001 for all end points). LV hypertrophy was a stronger predictor than CAC for CHD death, other CV death, and HF ( scores: 5.4 vs 3.4, 6.8 vs 2.4, and 9.7 vs 3.2 for LV hypertrophy vs CAC, respectively). Kaplan-Meier analysis demonstrated an increased risk of CV events in participants with LV hypertrophy, particularly after 5 years. Conclusion Elevated left ventricular mass was strongly associated with hard coronary heart disease events, other cardiovascular death, and heart failure over 15 years of follow-up, independent of traditional risk factors and coronary artery calcium score. © RSNA, 2019 See also the editorial by Hanneman in this issue.
背景 目前,针对经 MRI 量化的左心室(LV)质量升高与心血管(CV)事件的长期风险预测,仅有少量数据可参考,而这些数据主要来自当代不同种族的队列研究。目的 本研究旨在评估 LV 质量升高对多民族人群前瞻性队列研究中 CV 事件的长期影响,并探讨其与危险因素和冠状动脉钙评分(CAC)的关系。材料与方法 多民族动脉粥样硬化研究(Multi-Ethnic Study of Atherosclerosis,MESA)是一项正在进行的、以人群为基础的美国多中心前瞻性队列研究(NCT00005487)。2000 年至 2002 年期间,共有 6814 名无临床 CV 疾病的参与者(年龄 45-84 岁)入组本研究。在中位随访 15 年后的 4988 名参与者(2613 名[52.4%]女性;平均年龄 62 岁±10.1[标准差])中,基线时使用中心核心实验室的半自动软件从心脏 MRI 中得出 LV 质量。采用 Cox 比例风险模型、Kaplan-Meier 曲线和 C 统计量评估 LV 肥大的影响。结果 共有 290 名参与者发生硬 CV 事件(207 例心肌梗死[MI],95 例 CV 死亡),57 名参与者发生其他 CV 疾病相关死亡,215 名参与者发生心力衰竭(HF)。LV 肥大是硬 CV 事件(危险比[HR]:2.7;95%置信区间[CI]:1.9,3.8)、MI(HR:2.8;95% CI:1.8,4.0)、CV 死亡(HR:4.3;95% CI:2.5,7.3)、其他 CV 死亡(HR:7.5;95% CI:4.2,13.5)和 HF(HR:5.4;95% CI:3.8,7.5)的独立预测因素(所有终点的 P 值均<.001)。与 CAC 相比,LV 肥大对 CV 死亡、其他 CV 死亡和 HF 的预测作用更强(C 统计量:LV 肥大与 CAC 分别为 5.4 比 3.4、6.8 比 2.4 和 9.7 比 3.2)。Kaplan-Meier 分析显示,LV 肥大患者的 CV 事件风险增加,尤其是在 5 年后。结论 在中位随访 15 年后,LV 质量升高与硬 CV 事件、其他 CV 死亡和 HF 密切相关,其独立于传统危险因素和冠状动脉钙评分。